Response to Biosimilar Applicants.
Appears in 16 contracts
Sources: Collaboration and License Agreement (Shattuck Labs, Inc.), Exclusive Research Collaboration, License and Option Agreement (LogicBio Therapeutics, Inc.), License Agreement (CytomX Therapeutics, Inc.)